118 related articles for article (PubMed ID: 38519268)
1. Malignancy After Living Donor Liver Transplantation.
Kobayashi T; Miura K; Ishikawa H; Sakata J; Takizawa K; Hirose Y; Toge K; Saito S; Abe S; Kawachi Y; Ichikawa H; Shimada Y; Takahashi Y; Wakai T; Kinoshita Y
Transplant Proc; 2024 Apr; 56(3):660-666. PubMed ID: 38519268
[TBL] [Abstract][Full Text] [Related]
2. De Novo Malignancy After Adult-to-Adult Living Donor Liver Transplantation: A Single-Center Long-Term Experience.
Masuda Y; Mita A; Ohno Y; Kubota K; Notake T; Shimizu A; Soejima Y
Transplant Proc; 2023 May; 55(4):952-955. PubMed ID: 37088616
[TBL] [Abstract][Full Text] [Related]
3. Pretransplant Hepatic Malignancy Increases Risk of De Novo Malignancy after Liver Transplantation.
Park GC; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH; Yoon YI; Cho HD; Kwon JH; Chung YK; Kang SH; Choi JU; Jung IJ; Lee SG
J Korean Med Sci; 2020 Mar; 35(11):e69. PubMed ID: 32193900
[TBL] [Abstract][Full Text] [Related]
4. De Novo Malignancy Following Adult-to-Adult Living Donor Liver Transplantation Focusing on Posttransplantation Lymphoproliferative Disorder.
Mizuno S; Hayasaki A; Ito T; Fujii T; Iizawa Y; Kato H; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Usui M; Sakurai H; Isaji S
Transplant Proc; 2018 Nov; 50(9):2699-2704. PubMed ID: 30401380
[TBL] [Abstract][Full Text] [Related]
5. Retransplantation After Living Donor Liver Transplantation: Data from the Adult to Adult Living Donor Liver Transplantation Study.
Braun HJ; Grab JD; Dodge JL; Syed SM; Roll GR; Schwab MP; Liu IH; Glencer AC; Freise CE; Roberts JP; Ascher NL
Transplantation; 2021 Jun; 105(6):1297-1302. PubMed ID: 33347261
[TBL] [Abstract][Full Text] [Related]
6. Predictive Factors of De Novo Malignancies After Living-Donor Liver Transplantation: A Single-Center Experience.
Wahab MA; Abdel-Khalek EE; Elshoubary M; Yassen AM; Salah T; Sultan AM; Fathy O; Elmorshedi M; Shiha U; Elsadany M; Adly R; Samy M; Shehta A
Transplant Proc; 2021 Mar; 53(2):636-644. PubMed ID: 33549346
[TBL] [Abstract][Full Text] [Related]
7. Defining long-term outcomes with living donor liver transplantation in North America.
Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
[TBL] [Abstract][Full Text] [Related]
8. Development, management, and resolution of biliary complications after living and deceased donor liver transplantation: a report from the adult-to-adult living donor liver transplantation cohort study consortium.
Zimmerman MA; Baker T; Goodrich NP; Freise C; Hong JC; Kumer S; Abt P; Cotterell AH; Samstein B; Everhart JE; Merion RM
Liver Transpl; 2013 Mar; 19(3):259-67. PubMed ID: 23495079
[TBL] [Abstract][Full Text] [Related]
9. Acute liver failure in children-Is living donor liver transplantation justified?
Szymczak M; Kaliciński P; Kowalewski G; Broniszczak D; Markiewicz-Kijewska M; Ismail H; Stefanowicz M; Kowalski A; Teisseyre J; Jankowska I; Patkowski W
PLoS One; 2018; 13(2):e0193327. PubMed ID: 29474400
[TBL] [Abstract][Full Text] [Related]
10. Secondary non-resectable liver tumors: A single-center living-donor and deceased-donor liver transplantation case series.
Lerut J; Iesari S; Vandeplas G; Fabbrizio T; Ackenine K; Núñez MEI; Komuta M; Coubeau L; Ciccarelli O; Bonaccorsi-Riani E
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):412-422. PubMed ID: 31521538
[TBL] [Abstract][Full Text] [Related]
11. Living-donor liver transplantation at the University of Tokyo, 1996-2011: the impact of HLA matching and a positive crossmatch on long-term survival and tolerance.
Waki K; Sugawara Y; Mizuta K; Fujita H; Kadowaki T; Kokudo N
Clin Transpl; 2011; ():223-35. PubMed ID: 22755416
[TBL] [Abstract][Full Text] [Related]
12. New-onset diabetes mellitus after living-donor liver transplantation: association with graft synthetic function.
Yagi S; Kaido T; Iida T; Yoshizawa A; Okajima H; Uemoto S
Surg Today; 2017 Jun; 47(6):733-742. PubMed ID: 27837276
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study.
Terrault NA; Stravitz RT; Lok AS; Everson GT; Brown RS; Kulik LM; Olthoff KM; Saab S; Adeyi O; Argo CK; Everhart JE; Rodrigo del R;
Hepatology; 2014 Apr; 59(4):1311-9. PubMed ID: 24677192
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma and the risk of de novo malignancies after liver transplantation - a multicenter cohort study.
Shalaby S; Taborelli M; Zanetto A; Ferrarese A; D'Arcangelo F; Gambato M; Senzolo M; Russo FP; Germani G; Boccagni P; Ettorre GM; Baccarani U; Lauro A; Galatioto L; Rendina M; Petrara R; De Rossi A; Nudo F; Toti L; Fantola G; Vennarecci G; Risaliti A; Pinna AD; Gruttadauria S; Di Leo A; Rossi M; Tisone G; Zamboni F; Cillo U; Piselli P; Serraino D; Burra P;
Transpl Int; 2021 Apr; 34(4):743-753. PubMed ID: 33492715
[TBL] [Abstract][Full Text] [Related]
15. De Novo Malignancy After Living Donor Liver Transplantation: A Large Volume Experience.
Tiwari A; Saigal S; Choudhary NS; Saha S; Rastogi A; Bhangui P; Saraf N; Srinivasan T; Yadav SK; Gautam D; Nundy S; Soin AS
J Clin Exp Hepatol; 2020; 10(5):448-452. PubMed ID: 33029053
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus Drug Exposure Level and Smoking Are Modifiable Risk Factors for Early
Vanlerberghe BTK; van Malenstein H; Sainz-Barriga M; Jochmans I; Cassiman D; Monbaliu D; van der Merwe S; Pirenne J; Nevens F; Verbeek J
Transpl Int; 2024; 37():12055. PubMed ID: 38440132
[No Abstract] [Full Text] [Related]
17. High rates of de novo malignancy compromise post-heart transplantation survival.
Giuliano K; Canner JK; Etchill E; Suarez-Pierre A; Choi CW; Higgins RSD; Hsu S; Sharma K; Kilic A
J Card Surg; 2021 Apr; 36(4):1401-1410. PubMed ID: 33567114
[TBL] [Abstract][Full Text] [Related]
18. Healthcare utilization and outcomes of living donor liver transplantation for patients with APASL-defined acute-on-chronic liver failure.
Kulkarni AV; Reddy R; Sharma M; Iyengar S; Rambhatla A; Gv P; Menon B; Rao PN; Reddy N; Reddy KR
Hepatol Int; 2023 Oct; 17(5):1233-1240. PubMed ID: 37273169
[TBL] [Abstract][Full Text] [Related]
19. Living Donor Liver Transplantation for Acute Liver Failure: Donor Safety and Recipient Outcome.
Pamecha V; Vagadiya A; Sinha PK; Sandhyav R; Parthasarathy K; Sasturkar S; Mohapatra N; Choudhury A; Maiwal R; Khanna R; Alam S; Pandey CK; Sarin SK
Liver Transpl; 2019 Sep; 25(9):1408-1421. PubMed ID: 30861306
[TBL] [Abstract][Full Text] [Related]
20. The Risk of End-Stage Renal Disease Among Living Donor Liver Transplant Recipients in the United States.
Goldberg DS; Ruebner RL; Abt PL
Am J Transplant; 2015 Oct; 15(10):2732-8. PubMed ID: 25969133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
